MEDICUBE: Txa Niacinamide Capsule Cream (55g)

The management of chronic hyperpigmentation requires a sustained delivery of antioxidants and tyrosinase inhibitors.
This cream utilize a Tranexamic Acid (TXA) capsule system to provide a targeted intervention in the melanogenesis pathway.
Mechanistically, TXA functions by inhibiting the plasminogen activation system, which effectively reduces the inflammatory signals that trigger melanocyte overactivity.
This is critical for managing post-inflammatory hyperpigmentation (PIH) and melasma.
The formula is further enhanced by Niacinamide and Glutathione, which work as coordinated antioxidants to neutralize free radicals and block the transfer of melanin to surface keratinocytes.
To ensure these volatile molecules remain in their most potent state, the formula employs an encapsulation technology that protects the actives until they are mechanical released during application.
Upon contact with the skin, the capsules rupture, providing a concentrated surge of double-toning energy.
This process ensures maximum bioavailability and efficacy.
Furthermore, the inclusion of barrier-identical lipids helps to reinforce the stratum corneum, significantly reducing transepidermal water loss (TEWL) and improving skin resilience.
Clinical trials have demonstrated that this combination leads to a visible improvement in skin clarity and tone uniformity within a four-week cycle.
By maintaining the skin in a reduced oxidative state and protecting the structural proteins of the dermis, the formulation ensures a long-term improvement in both texture and luminosity.
This scientific approach provides a professional-grade solution for achieved a clear and radiant complexion, fulfilling the clinical requirements for systemic pigment modulation and structural health in patients with pigmented or mature skin.

How to use:
• Step 1: Apply as the final step in your PM routine.
• Step 2: Smooth evenly over the face and neck.
• Step 3: Gently massage to rupture the active capsules.
• Step 4: Pat gently to facilitate full barrier integration.